Cheranov, Sergey Y., and Jonathan H. Jaggar. TNF-␣ dilates cerebral arteries via NAD(P)H oxidase-dependent Ca 2ϩ spark activation.
cerebrovascular circulation; ryanodine-sensitive Ca 2ϩ release channel; Ca 2ϩ -activated K ϩ channel; reactive oxygen species; vasodilation STROKE AND TRANSIENT BRAIN ISCHEMIA are vasculature-borne brain pathologies accompanied by inflammatory changes in blood vessels and parenchymal tissues (15, 46) . TNF-␣, a pleiotropic cytokine, is a proinflammatory agent generated by glial cells, neurons, macrophages, and vascular endothelium during brain injury. Clinical data demonstrate a correlation between TNF-␣ levels and the severity of ischemic brain damage, but controversy exists regarding the functional role of TNF-␣, with both beneficial and detrimental roles having been proposed (3, 8, 9, 15, 36, 46) . Chronic TNF-␣ elevation is associated with risk factors for other vascular pathologies, including coronary artery disease and atherosclerosis (26) . During stroke, TNF-␣ may cause neuronal damage directly and by accelerating ischemia-induced local inflammatory responses. In contrast, studies also indicate that TNF-␣ may be cytoprotective (8, 15, 36, 46) . TNF-␣ acts in a paracrine manner by binding to two membrane receptors, p55 and p75. Besides its actions on neurons, astrocytes, and microglia, TNF-␣ also regulates arterial contractility (15) , an effect that may modulate injury by altering local blood supply. However, the regulation of arterial diameter and blood flow by TNF-␣ is complex. Intracranial injection of TNF-␣ in vivo constricted pial arterioles and reduced cerebral blood flow (29, 38, 44) . TNF-␣ also induced procontractile effects in coronary arteries (23, 51) . In contrast, TNF-␣ dilated cerebral, mesenteric, and cremaster muscle arterioles and relaxed endothelium-denuded aortas (4, 7, 16, 22, 32, 37) . In bronchial arteries, TNF-␣ initially induced dilation, followed by constriction 2 h later (45) . TNF-␣-mediated vasoregulation can also occur through both endothelium-dependent and endothelium-independent mechanisms (4, 7, 16, 22, 23, 29, 32, 37, 38, 44, 45, 51) . Collectively, data suggest that TNF-␣ can induce both vasoconstriction and vasodilation and that its effects may be time dependent. Regardless of these data, the mechanisms that mediate vasoregulation by TNF-␣ are poorly understood.
A major regulator of arterial diameter is the smooth muscle cell global intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ). In smooth muscle cells, global [Ca 2ϩ ] i is regulated by extracellular Ca 2ϩ influx and intracellular Ca 2ϩ release (19) . An elevation in global [Ca 2ϩ ] i induces constriction, whereas a decrease in global [Ca 2ϩ ] i leads to vasodilation. Another Ca 2ϩ signal, termed a Ca 2ϩ spark, is a rapid, localized intracellular Ca 2ϩ transient that occurs as a result of the activation of several ryanodine-sensitive Ca 2ϩ release (RyR) channels on the sarcoplasmic reticulum (SR) (19, 33 ] i and vasodilation (19, 33) . In contrast, Ca 2ϩ spark inhibition leads to vasoconstriction due to depolarization-induced voltage-dependent Ca 2ϩ channel activation (19) . Alterations in Ca 2ϩ sparks and effective coupling to K Ca channels have been implicated in hypertension and diabetes (1, 6, 19, 31 waves, when stimulated, contribute Ca 2ϩ for contraction (35) . The goal of the present study was to investigate whether TNF-␣ regulates cerebral artery diameter by modulating smooth muscle Ca 2ϩ signaling and, if so, to determine the underlying mechanisms. Such information would improve the understanding of cytokine-mediated changes in arterial diameter during vascular pathologies, including stroke.
METHODS

Tissue Preparation and Single-Cell Isolation
Sprague-Dawley rats (ϳ250 g) of either sex were euthanized by administering an intraperitoneal injection of a pentobarbital sodium overdose (150 mg/kg body wt) in accordance with the policies and procedures of the Animal Care and Use Committee at the University of Tennessee. The brains were removed and placed into ice-cold (4°C) oxygenated (95% O 2-5% CO2) physiological salt solution (PSS) containing (in mM) 119 NaCl, 4.7 KCl, 24 NaHCO3, 1.2 KH2PO4, 1.6 CaCl 2, 1.2 MgSO4, 0.023 EDTA, and 11 glucose. The posterior cerebral, middle cerebral, and cerebellar arteries (50 -200 m in diameter) were removed, cleaned of connective tissue, and maintained in ice-cold PSS. When appropriate, the endothelium was removed by introducing an air bubble into the arterial lumen for 2 min, followed by a 30-s wash with H 2O. Individual smooth muscle cells were dissociated from cerebral arteries using enzymes and an isolation solution composed of (in mM) 55 NaCl, 80 sodium glutamate, 5.6 KCl, 2 MgCl 2, 10 HEPES, and 10 glucose (pH 7.3 with NaOH) as previously described (18) . Cells were stored on ice and used for experiments between 1 and 6 h after isolation.
Laser-Scanning Confocal Ca 2ϩ Imaging
Artery segments (1-2 mm in length) were placed into HEPESbuffered PSS composed of (in mM) 134 NaCl, 6 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose (pH 7.4, NaOH) containing fluo-4 AM (10 M) and Pluronic F-127 (0.05%) for 60 min at 22°C. To allow for indicator deesterification, the arteries were subsequently placed into HEPES-buffered PSS for 30 min at 22°C. Smooth muscle cells within the arterial wall were scanned using an OZ laser-scanning confocal microscope (Noran Instruments, Middleton, WI) and a ϫ60 magnification water-immersion lens objective (numerical aperture 1.2) attached to a TE300 microscope (Nikon). Cells were illuminated using a krypton-argon laser at 488 nm, and emitted light Ͼ500 nm was collected. 
Patch-Clamp Electrophysiology
K
ϩ currents were measured using either the conventional whole cell or perforated configuration of the patch-clamp technique with an Axopatch 200B amplifier (Axon Instruments, Union City, CA). Bath solution was 6 mM K ϩ HEPES-buffered PSS (composition described above). For perforated patch-clamp experiments, the pipette solution contained (in mM) 110 potassium aspartate, 30 KCl, 10 NaCl, 1 MgCl 2, 10 HEPES, and 0.05 EGTA (pH 7.2 maintained using KOH). For conventional whole cell experiments, the pipette solution contained (in mM) 140 KCl, 1.9 MgCl 2, 0.037 CaCl2, 0.1 EGTA, 10 HEPES, and 2 Na 2ATP (pH 7.2 maintained using KOH); the calculated free Ca 2ϩ and free Mg 2ϩ concentrations of this solution were 100 nM and 1 mM, respectively (WEBMAXC; Stanford University, Palo Alto, CA). In some experiments, 200 U/ml catalase was included in the whole cell pipette solution. When appropriate, catalase was heat inactivated by incubation at 92°C for 25 min. TNF-␣ was applied to the bath solution 10 min after formation of the whole cell configuration to ensure exchange of the pipette solution with the cytosol. All experiments were performed using a holding potential of Ϫ40 mV. Membrane currents were recorded using a sample rate of 2.5 kHz and filtered at 1 kHz. Transient K Ca current analysis was performed offline. A transient KCa current was defined as the simultaneous opening of three or more KCa channels.
Reactive Oxygen Species Measurements
Dichlorofluorescein imaging. Reactive oxygen species (ROS) were measured in isolated intact arterial segments using 2Ј,7Ј-dichlorodihydrofluorescein diacetate (H 2DCFDA). Isolated endothelium-denuded cerebral artery segments (1-2 mm) were incubated for 45 min at room temperature in 10 M H 2DCFDA. H2DCFDA is hydrolyzed by intracellular esterases to the nonfluorescent derivative dichlorodihydrofluorescein (H 2DCF). ROS oxidize H2DCF to fluorescent dichlorofluorescein (DCF). DCF fluorescence was excited with 488 nm of light, and emitted light Ͼ525 nm was collected. Planar images were acquired using a Zeiss LSM5 laser-scanning confocal microscope. Images were recorded 10 min after TNF-␣ or H 2O2 application. Time controls were also performed in which agents were not applied. Because DCF fluorescence increases spontaneously upon exposure to excitation light (12) , arterial regions were scanned only once. Images were background corrected. ImageJ software (National Institutes of Health, Bethesda, MD) was used for analysis.
Dihydroethidium imaging. Cerebral arterial segments were incubated for 20 min in HEPES-buffered PSS without (time-matched control) or with TNF-␣. Arteries were then embedded in OTC and snap-frozen in liquid N 2. Transverse sections 30 m thick were cut, mounted onto glass slides, and incubated with 10 M dihydroethidium (DHE) in a 100% N 2 atmosphere in the dark for 30 min at 37°C. Arterial sections were excited with 488 nm light, and emitted light Ͼ590 nm was collected using an OZ laser-scanning confocal microscope. Custom-written software was used to measure DHE fluorescence intensity. Fluorescence intensity in TNF-␣ was divided by that in time-matched controls to determine the effects of TNF-␣ on DHE intensity. Tissue processing did not elevate ROS, because the DHE fluorescence intensity of arteries preincubated with Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP) was 1.04 Ϯ 0.06-fold of those that were left untreated (n ϭ 5; P Ͼ 0.05).
Pressurized Artery Diameter Measurements
Cerebral arterial segments (100 -200 m diameter) were placed in a temperature-controlled perfusion chamber (Living Systems Instrumentation, Burlington, VT) and cannulated with glass pipettes at each end. The chamber was perfused continuously with PSS equilibrated with 5% CO 2, 21% O2, and 74% N2, pH 7.4, and maintained at 37°C. Arteries were observed using a charge-coupled device camera attached to an inverted microscope (TS100F; Nikon). Arterial diameter was monitored using edge detection software (IonWizard; IonOptix, Milton, MA). Arterial intraluminal pressure was elevated to 60 mmHg, which resulted in the development of myogenic tone. After diameter stabilization, tested agents were applied using chamber perfusion. Arterial diameter was digitized at 1 Hz using the edge detection function of IonWizard software. Endothelial denudation was confirmed by the absence of a dilatory response to carbachol (10 Ϫ5 M), an endothelium-dependent cerebral vasodilator. At the end of each experiment, passive arterial diameter was determined using a Ca 2ϩ -free bath solution containing 1 mM EGTA.
Data Analysis
Data are expressed as means Ϯ SE. Student's t-test was used to compare paired and unpaired data from two populations, and ANOVA and the Student-Newman-Keuls test were used for multiple-group comparisons. Evaluation of whether distributions were Gaussian using the method of Kolmogorov and Smirnov. P Ͻ 0.05 was considered significant.
Chemicals
Unless stated otherwise, all chemicals used in this study were obtained from Sigma (St. Louis, MO) or Calbiochem (San Diego, CA). Papain was purchased from Worthington Biochemical (Lakewood, NJ), fluo-4 AM and H 2DCFDA were obtained from Molecular Probes (Eugene, OR), and rat recombinant TNF-␣ was purchased from BD Pharmingen (San Diego, CA).
RESULTS
TNF-␣ Activates Ca 2ϩ Sparks and Ca 2ϩ Waves and Reduces Global [Ca 2ϩ ] i in Smooth Muscle Cells of Intact Cerebral Arteries
The regulation of local and global Ca 2ϩ signals in smooth muscle cells by TNF-␣ was measured in cerebral artery segments. TNF-␣ (50 ng/ml) increased mean Ca 2ϩ spark frequency from 1.53 Ϯ 0.16 Hz to 2.6 Ϯ 0.51 Hz, or ϳ1.7-fold (Fig. 1, A and B) . TNF-␣ did not change Ca 2ϩ spark amplitude (control F/F 0 , 1.36 Ϯ 0.01, n ϭ 184 sparks, and TNF-␣ F/F 0 , 1.34 Ϯ 0.01, n ϭ 329 sparks; P Ͼ 0.05). In the same cells, TNF-␣ also elevated mean Ca 2ϩ wave frequency from 0.32 Ϯ 0.02 Hz to 0.48 Ϯ 0.03 Hz, or ϳ1.5-fold (Fig. 1C) . In contrast, TNF-␣ decreased mean global [Ca 2ϩ ] i to 0.85 Ϯ 0.02 of control (n ϭ 6 arteries, P Ͻ 0.05). These experiments suggest TNF-␣ elevates Ca 2ϩ spark and wave frequency and reduces global [Ca 2ϩ ] i in cerebral arterial smooth muscle cells.
TNF-␣ Activates NAD(P)H Oxidase Leading to a ROS Elevation in Smooth Muscle Cells of Intact Cerebral Arteries
TNF-␣ activates ROS generation in smooth muscle cells (13) . Because RyR channels are redox sensitive (42), we tested the hypothesis that TNF-␣ regulates local Ca 2ϩ signaling by elevating intracellular ROS. Several enzymes generate ROS including NAD(P)H oxidase, xanthine oxidase, cytochrome P450, and mitochondrial electron transport chain complexes (13, 28, 41, 49) . The DCF and DHE fluorescence methods were used to determine the pathways through which TNF-␣ elevates ROS in the smooth muscle cells of small cerebral arteries. TNF-␣ increased DCF fluorescence intensity 2.7 Ϯ 0.32-fold and DHE intensity 1.51 Ϯ 0.03-fold in the smooth muscle cells of intact arteries (Fig. 2, A-D) . During the same period, H 2 O 2 elevated DCF fluorescence 4.7 Ϯ 0.68-fold, whereas DCF fluorescence did not change in controls (absence of applied agents) (Fig. 2B) . In the presence of apocynin or diphenyleneiodonium (DPI), which are NAD(P)H oxidase blockers, TNF-␣ did not elevate DCF fluorescence (Fig. 2B) . MnTMPyP, a membrane-permeant O 2 Ϫ ⅐ and catalase mimetic, also prevented the TNF-␣-induced DCF fluorescence elevation (Fig. 2B) . Apocynin (1.07 Ϯ 0.23-fold vs. control; n ϭ 5), DPI (0.85 Ϯ 0.1-fold vs. control; n ϭ 4), and MnTMPyP (1.14 Ϯ 0.17-fold vs. control; n ϭ 4) did not change ROS when applied alone (P Ͼ 0.05 for each). TNF-␣-induced DCF fluorescence elevations were not reduced by oxypurinol, a xanthine oxidase inhibitor; 17-octadecanoic acid, a cytochrome P450 blocker; or 
TNF-␣ Activates Transient K Ca Currents in Isolated Arterial Smooth Muscle Cells
In arterial smooth muscle cells, a Ca 2ϩ spark activates several K Ca channels, resulting in a transient K Ca current that induces membrane hyperpolarization (19) . To investigate the effects of TNF-␣-induced changes in Ca 2ϩ signaling, transient K Ca current regulation by TNF-␣ was measured in isolated, voltage-clamped (Ϫ40 mV) arterial smooth muscle cells. When using the perforated patch-clamp configuration, TNF-␣ evoked a gradual increase in transient K Ca current frequency and amplitude that reached a steady-state elevation of ϳ1.7-and ϳ1.4-fold, respectively, in ϳ10 min (Fig. 3, A, C, and D) . Similar observations were made when using the conventional whole cell configuration (Fig. 3, B-D) . Apocynin did not alter transient K Ca current frequency (0.89 Ϯ 0.12-fold vs. control; n ϭ 6) or amplitude (1.0 Ϯ 0.06-fold vs. control; n ϭ 6) when applied alone (P Ͼ 0.05 for each) but reversed the TNF-␣-induced increase in transient K Ca current frequency and amplitude (Fig. 3, B-D) . These data suggest that TNF-␣ stimulates transient K Ca currents by activating NAD(P)H oxidase.
TNF-␣-induced intracellular signaling may involve mitochondrial PTP activation and ceramide generation (14, 22, 28, 30, 39, 41, 52) . However, ceramide did not alter transient K Ca currents, indicating that it is unlikely to mediate TNF-␣-induced activation of these events (Fig. 3, C and D) . Lonidamine decreased mean Ca 2ϩ spark frequency from 1.45 Ϯ 0.16 Hz to 0.73 Ϯ 0.18 Hz, or ϳ0.5-fold compared with control (n ϭ 4; P Ͻ 0.05) and inhibited transient K Ca currents (10).
Similarly, atractyloside, another mitochondrial PTP opener, decreased transient K Ca current frequency and amplitude (Fig.  3, C and D) . These data demonstrate that PTP openers inhibit transient K Ca currents, indicating that such an effect cannot mediate TNF-␣-induced transient K Ca current activation.
To determine whether TNF-␣-induced transient K Ca current activation occurs as a result of a ROS elevation, we measured transient K Ca current regulation by MnTMPyP as well as by catalase that converts H 2 O 2 to H 2 O. MnTMPyP reversed TNF-␣-induced elevations in transient K Ca current frequency and amplitude (Fig. 4, A-C) . In contrast, MnTMPyP did not change transient K Ca current frequency (1.0 Ϯ 0.1-fold vs. control; n ϭ 5) or amplitude (1.0 Ϯ 0.07-fold vs. control) when applied alone (P Ͼ 0.05 for each). Similarly, when the conventional whole cell configuration was used, inclusion of catalase in the pipette solution (to allow intracellular access) prevented TNF-␣-induced transient K Ca current activation (Fig. 4, B  and C) . In contrast, when the pipette solution was supplemented with heat-inactivated catalase, TNF-␣ increased transient K Ca current frequency and amplitude ϳ1.8-and ϳ1.4-fold, respectively (Fig. 4, B and C) . In summary, these data indicate that TNF-␣ activates Ca 2ϩ sparks and transient K Ca currents by inducing an NAD(P)H oxidase-mediated ROS elevation.
TNF-␣ Dilates Pressurized Cerebral Arteries by Elevating ROS, SR Ca 2ϩ -ATPase Release, and K Ca Channel Activity
TNF-␣ has been demonstrated to induce both vasoconstriction and vasodilation by endothelium-dependent and endothelium-independent pathways (4, 7, 16, 22, 23, 29, 32, 37, 38, 44, 51) . The data reported herein suggest that TNF-␣ activates a dilatory Ca 2ϩ signaling pathway in the smooth muscle cells of small, resistance-sized cerebral arteries. Therefore, vasoregulation by TNF-␣ was investigated using resistance-sized, pressurized (60 mmHg) cerebral arteries. In endothelium-intact arteries, from a mean active diameter of 142 Ϯ 3 m (0.64 Ϯ 0.01-fold vs. passive diameter), TNF-␣ induced a mean dila- (Fig. 5, A-C) . In endothelium-denuded arteries, TNF-␣ increased mean diameter by 18 Ϯ 3 m from 130 Ϯ 9 m (0.57 Ϯ 0.02-fold vs. passive diameter) (Fig. 5C ). TNF-␣-induced dilations were not significantly different in endothelium-intact or endothelium-denuded arteries (P Ͼ 0.05). TNF-␣-induced dilations were fully reversible (Fig. 5A) , and consecutive TNF-␣ applications resulted in dilations of similar magnitude (first application, 19 Ϯ 2 m; second application, 21 Ϯ 2 m) (n ϭ 2).
To investigate the importance of ROS generation in TNF-␣-induced vasodilation, responses to TNF-␣ were measured in control and then in the presence of MnTMPyP (10 M) in the same artery. MnTMPyP reduced mean TNF-␣-induced vasodilation to 7 Ϯ 2 m or to 0.34 Ϯ 0.03 of control dilations (Fig.  5C ). The same protocol was performed with thapsigargin (100 nM), a SR Ca 2ϩ -ATPase blocker that inhibits Ca 2ϩ sparks, or iberiotoxin (100 nM), a selective K Ca channel blocker (19) . Thapsigargin reduced mean TNF-␣-induced vasodilation to (Fig. 5C) . Similarly, iberiotoxin reduced mean TNF-␣-induced vasodilation to 6 Ϯ 1 m, or to 0.29 Ϯ 0.05 of control (Fig. 5, B and C) . These data indicate that TNF-␣ dilates cerebral arteries by generating ROS that stimulate Ca 2ϩ sparks and K Ca channels in smooth muscle cells.
DISCUSSION
In the present study, we investigated the mechanisms by which TNF-␣, a pleiotropic cytokine, regulates the diameter of small cerebral arteries. Our data indicate that TNF-␣ activates smooth muscle cell NAD(P)H oxidase, leading to the generation of ROS that activate Ca 2ϩ sparks and thus transient K Ca currents. The ensuing decrease in global [Ca 2ϩ ] i leads to vasodilation. These findings show for the first time that an inflammatory mediator that is central to a variety of vascular diseases induces vasodilation through Ca 2ϩ spark activation. TNF-␣ is produced in the brain during ischemia and is implicated in the etiology of several cardiovascular diseases, including stroke, cardiac failure, coronary artery disease, and atherosclerosis (15, 46) . TNF-␣ is reported to induce both vasoconstriction and vasodilation. Topical application of TNF-␣ dilated cerebral arterioles (7, 37) , whereas intracranial injection of TNF-␣ induced cerebrovascular constriction and reduced blood flow (29, 38, 44) . TNF-␣ also dilated mesenteric and cremaster muscle arterioles (4, 32, 45) . Earlier studies suggested that TNF-␣ promotes vasodilation by elevating nitric oxide (NO) and prostaglandin production in the arterial wall and in perivascular tissues (4, 7, 37). In contrast, in pulmonary arterial rings, a hypoxia-induced increase in TNF-␣ mRNA was associated with contraction (43) . TNF-␣ also reduced bradykinin-and ACh-induced vasodilation in rat mesenteric arteries (48) and bradykinin-and A23187-induced vasodilation in bovine coronary arteries (51), blunted ACh-induced vasodilation in cat carotid arteries (2), and evoked endotheliumdependent vasoconstriction in human and rat coronary arteries (17, 23) . In humans, intrabrachial TNF-␣ injection impaired bradykinin-and ACh-induced vasodilation (11) . Data also suggest that TNF-␣ inhibits vasodilation by triggering ROS that scavenge endothelial NO (51) . It is unclear what underlies differential regulation of arterial contractility by TNF-␣, but several possibilities exist. Vasoregulatory actions of TNF-␣ may be vascular bed specific. Different experimental protocols used may also explain the diversity of observations reported in various studies. In addition, the effects of TNF-␣ on arterial contractility may be time dependent. For example, in sheep bronchial arteries, TNF-␣ initially induced dilation, followed by constriction 2 h later (45) . Data also suggest that differential effects on contractility may occur when TNF-␣ acts primarily on either endothelial or smooth muscle cells. Conceivably, TNF-␣-induced vasoconstriction might occur primarily as a result of an endothelium-dependent mechanism, whereas vasodilation may be mediated by a direct effect on smooth muscle cells. Here, we have shown that in isolated, pressurized, myogenic rat cerebral arteries, acute TNF-␣ application (Ͻ30 min) induced vasodilation that was endothelium independent and was markedly attenuated by an antioxidant and inhibitors of SR Ca 2ϩ release and K Ca channels. TNF-␣ activates several signaling pathways in vascular smooth muscle cells. TNF-␣ stimulated NAD(P)H oxidase, leading to ROS production in rat aortic smooth muscle cells (13) . TNF-␣ relaxed endothelium-denuded, phenylephrineconstricted aortic rings via PLA 2 activation, implicating ceramide as a mediator (22) . In cardiac and endothelial cells, signaling mechanisms for TNF-␣ involve mitochondria (20, 23-25, 35, 36) . TNF-␣ disrupted the mitochondrial electron transport chain, caused release of cytochrome c, induced mitochondrial ROS generation, and triggered apoptosis (14, 28, 30, 41, 52) . Although the downstream intramitochondrial target for TNF-␣ is unclear, PTP involvement was proposed in endothelial cells (52) . PTP is also a downstream target for TNF-␣-induced signaling in other cell types, and PTP opening may be triggered by electron transport chain inhibition and mitochondrial depolarization (5, 10, 39) . Ceramide had no effect on transient K Ca currents, and PTP openers inhibited these events, consistent with the findings reported in a previous study of arterial smooth muscle cells (10) . Therefore, TNF-␣ is unlikely to activate Ca 2ϩ sparks and transient K Ca currents by elevating ceramide or by inducing PTP opening. In some cell types, including neutrophils, preincubation with apocynin is required to block association of NAD(P)H oxidase subunits (40) . Here, we have shown that in cerebral artery smooth muscle cells, apocynin reverses TNF-␣-induced transient K Ca current activation within ϳ10 min. This effect may reflect rapid subunit turnover in the presence of TNF-␣ in these cells. Our present data indicate that TNF-␣ stimulates NAD(P)H oxidase, generating ROS that activate Ca 2ϩ sparks and transient K Ca currents in cerebral artery smooth muscle cells. These findings are consistent with those described in a recent study that reported mitochondria-derived ROS activate Ca 2ϩ sparks and transient K Ca currents in arterial smooth muscle Fig. 5 . TNF-␣ dilates pressurized (60 mmHg) cerebral arteries by elevating ROS and activating sarcoplasmic reticulum (SR) Ca 2ϩ release and KCa channels. A: TNF-␣ reversibly dilated a pressurized (60 mmHg) endotheliumintact cerebral artery. B: 10 ng/ml TNF-␣-induced vasodilation was inhibited by 100 nM iberiotoxin (IBTX). C: mean 10 ng/ml TNF-␣-induced dilation in endothelium-intact arteries in control (Cntrl; n ϭ 29), MnTMPyP (MnT, 10 M; n ϭ 4), thapsigargin (ϩTg, 100 nM; n ϭ 7), iberiotoxin (ϩIBTX, 100 nM; n ϭ 9), and endothelium-denuded arteries (Denud; n ϭ 6). MnTMPyP reduced arterial diameter by 4 Ϯ 1 m (n ϭ 4; P Ͻ 0.05). Thapsigargin and IBTX reduced mean arterial diameter by 9 Ϯ 3 m and 9 Ϯ 1 m, respectively (P Ͻ 0.05 for each), consistent with Ca 2ϩ spark and KCa channel inhibition (19 ROS production or inhibition of ROS degradation leads to vasoconstriction, high blood pressure, and vascular hypertrophy (24) . However, ROS also stimulate vasodilation. For example, flow-mediated vasodilation occurs because of the generation of mitochondria-derived H 2 O 2 (27) . Furthermore, topical application of ROS dilates cerebral arteries in vivo (47) . Thus ROS induce both vasoconstriction and vasodilation. Conceivably, there might be a delicate balance between ROS concentrations that regulate physiological functions and higher ROS concentrations that lead to pathologies (24) . The data reported herein indicate that TNF-␣ regulates Ca 2ϩ sparks by generating ROS from a single source, NAD(P)H oxidase. During disease, vasoconstriction may result from ROS produced in higher concentrations, from additional enzymes, from exogenous sources, and for prolonged periods. For example, oxyhemoglobin, which may contribute to vasoconstriction after subarachnoid hemorrhage, inhibits Ca 2ϩ sparks in cerebral artery smooth muscle cells, and this effect can be blocked by antioxidants (21) . TNF-␣ receptors were recently proposed to confine NAD(P)H oxidase-mediated redox signaling spatially in human microvascular endothelial cells (25) . TNF-␣ may also activate Ca 2ϩ sparks by elevating ROS in the local vicinity of Ca 2ϩ spark sites. Through restriction, the global effects of ROS could be lessened and dilatory signaling could be maintained. Because Ca 2ϩ spark sites are close to sarcolemmal K Ca channels, local NAD(P)H oxidase-derived ROS should also regulate K Ca channel activity. TNF-␣ did not alter Ca 2ϩ spark amplitude but increased transient K Ca current amplitude. NAD(P)H oxidase inhibitors and antioxidants reduced the TNF-␣-induced transient K Ca current amplitude elevation, indicating that the effect was mediated by NAD(P)H oxidasederived ROS. Thus TNF-␣ also enhances the effective coupling of Ca 2ϩ sparks to K Ca channels, presumably by elevating K Ca channel Ca 2ϩ sensitivity within the micromolar concentration range generated by these Ca 2ϩ transients (34) . The combined effects of elevated Ca 2ϩ spark frequency and transient K Ca current amplitude could significantly increase K Ca channel activity, leading to vasodilation (19, 33 (19) . Therefore, the net effect of TNF-␣-induced Ca 2ϩ spark and Ca 2ϩ wave activation is a reduction in the global [Ca 2ϩ ] i , leading to vasodilation. In summary, in this study, we have defined a novel vasodilatory signaling pathway for an inflammatory cytokine mediated by Ca 2ϩ spark and K Ca channel activation in smooth muscle cells. After ischemia and stroke, TNF-␣-induced Ca 2ϩ spark activation and cerebrovascular dilation would be important in regulating local blood supply in the affected brain region.
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